Pennsylvania Medicaid and semaglutide
Wegovy for weight loss: no. Not covered for overweight or obesity. Other medically accepted uses are covered with prior authorization, with a step through Ozempic. Ozempic for weight loss: no; for type 2 diabetes Pennsylvania Medicaid must cover it. Read from Pennsylvania Department of Human Services, Office of Medical Assistance Programs documents Nov 6, 2026.
In 2025 Pennsylvania Medicaid paid for 485,068 semaglutide prescriptions (Wegovy, Ozempic, Rybelsus), 57% of its GLP-1 prescriptions and 3rd of the 50 states and DC. It reimbursed $562.8 million before rebates, $1,160 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Wegovy | 247,331 | $324.6 million | $1,312 |
| Ozempic | 234,746 | $235.3 million | $1,002 |
| Rybelsus | 2,991 | $3.0 million | $993 |
Pennsylvania plans and prescribing rules
Independence Blue Cross (IBX). Independence Blue Cross stopped covering drugs prescribed solely for weight loss, GLP-1s included, on January 1, 2025 or at plan renewal. Members whose employer adds a weight loss benefit keep GLP-1 coverage.
Semaglutide in the states around Pennsylvania
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Pennsylvania | 19 | $39/moWellmedr | 485,068 | Medicaid Wegovy: No |
| Delaware | 19 | $39/moWellmedr | 36,313 | Medicaid Wegovy: Unclear |
| Maryland | 19 | $39/moWellmedr | 109,871 | Medicaid Wegovy: No |
| New Jersey | 19 | $39/moWellmedr | 71,402 | Medicaid Wegovy: Not covered (KFF) |
| New York | 19 | $39/moWellmedr | 488,820 | Medicaid Wegovy: No |
| Ohio | 19 | $39/moWellmedr | 26,519 | Medicaid Wegovy: No |
| West Virginia | 18 | $39/moWellmedr | 75,835 | Medicaid Wegovy: No |



